CG Oncology, Inc. (CGON) stock forecast and price target
Price $74.40 · data as of November 13, 2026
12-month price target
Average target$92.15
Upside / downside+23.9%
Analysts13
ConsensusStrong buy
Low $80.00Average $92.15High $112.00
Gold marker: average target · white marker: today’s price ($74.40)
Analyst ratings
Strong buy 4Buy 9Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.93 | −40.9% | $5M |
| Next fiscal year ends December 31, 2027 | $-2.88 | +1.8% | $95M |
| Next quarter ends December 31, 2026 | $-0.71 | −38.6% | $727000 |
| Quarter after ends March 31, 2027 | $-0.74 | −3.8% | $400000 |
Consensus of the analysts covering CG Oncology, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the CG Oncology stock price target?
The average 12-month target from 13 analysts is $92.15, 23.9% above the current price of $74.40 Targets range from $80.00 to $112.00.
Is CG Oncology a buy according to analysts?
The consensus rating is “Strong buy” (4 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is CG Oncology expected to earn?
Analysts expect EPS of $-2.93 for the fiscal year ending December 31, 2026 and $-2.88 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.